XTAI
1736
Market cap1.17bUSD
Oct 08, Last price
123.00TWD
1D
0.82%
1Q
-6.46%
Jan 2017
164.80%
IPO
543.31%
Name
Johnson Health Tech Co Ltd
Chart & performance
P/E
13.57
P/S
0.69
EPS
9.06
Div yield, %
3.25%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
13.88%
Revenues
54.33b
+13.69%
Net income
2.75b
+13.16%
CFO
2.58b
+144.59%
Dividend
Aug 04, 20264.5 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Johnson Health Tech. Co., Ltd. is a prominent global supplier specializing in the production and distribution of health and fitness equipment. Their diverse product lineup includes a wide array of cardiovascular and strength training machines, alongside integrated electronic components and a dedicated video streaming service. Operating worldwide, the company serves key markets across the Americas, Europe, and Asia, with a notable presence in China. Beyond their core fitness offerings, Johnson Health Tech also researches, develops, and markets therapeutic massage chairs, and provides a selection of food products. The enterprise was founded in 1975 and is headquartered in Taichung City, Taiwan.
Key people
James Chan
Assistant General Manager of Finance, Corporate Governance Officer · since 2023
Hsiao-Tzu Fang
General Manager-Asia Digital Marketing · since 2022
Sean Juo
General Manager-Taiwan Factory · since 1999
An-Ping Lin
Chief Marketing Officer-Global Consumer · since 2022
Simon Fang
General Manager-Sales · since 2023
Jason Lo
Chief Executive Officer, General Manager, Director · since 2005
Vic Chen
Deputy General Manager-General Management Division · since 2011
William Chu
Deputy General Manager-General Management Division · since 2009
Jean Hung
Deputy General Manager-Marketing Business Division · since 1975
Philip Lai
Deputy General Manager-Sales Division · since 2015
Pendy Liao
Deputy General Manager-R&D Division · since 1994
William Poon
Deputy General Manager-Sales Division · since 1998
Max Yen
Deputy General Manager-General Management Division · since 2001
Jacky Lee
Assistant General Manager-Accounting Division · since 2015
Po Chang Chen
Director · since 2023
Spencer Hsieh
Director · since 2008
Yih-Horng Lin
Director · since 2023
Christa Lin
Director · since 2023
Teresa Lo
Director · since 2017
Cindy Lo
Vice Chairman of the Board · since 2014
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||